Unexpected Role of Plasminogen Activator Inhibitor 1 in Cell Adhesion and Detachment
- 1 December 2004
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 229 (11) , 1090-1096
- https://doi.org/10.1177/153537020422901102
Abstract
Plasminogen activator inhibitor 1 (PAI-1) is the primary physiological inhibitor of plasminogen activation in vivo, and thus it is one of the main regulators of the fibrinolytic system. In this regard, individuals with elevated PAI-1 seem to have an increased risk for thrombotic disease, whereas those lacking the inhibitor develop a lifelong bleeding diathesis. Unexpectedly, recent observations demonstrate that cancer patients with high PAI-1 levels have a poor prognosis for survival. This correlation with metastatic disease may be related to the observation that high PAI-1 levels decrease the adhesive strength of cells for their substratum, and that this de-adhesive activity of PAI-1 is not related to its role as a protease inhibitor. Initial insights into potential mechanisms by which PAI-1 regulates the attachment, detachment, and migration of cells are addressed in this review.Keywords
This publication has 37 references indexed in Scilit:
- Plasminogen activator inhibitor-1 and tumour growth, invasion, and metastasisThrombosis and Haemostasis, 2004
- Sequences within Domain II of the Urokinase Receptor Critical for Differential Ligand RecognitionJournal of Biological Chemistry, 2003
- Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrinsThe Journal of cell biology, 2003
- Kinetic Analysis of the Interaction between Vitronectin and the Urokinase ReceptorJournal of Biological Chemistry, 2002
- Plasminogen activator inhibitor‐1 regulates cell adhesion by binding to the somatomedin B domain of vitronectinJournal of Cellular Physiology, 2001
- Inhibition of Angiogenesis in Vivo by Plasminogen Activator Inhibitor-1Journal of Biological Chemistry, 2001
- Urokinase-type Plasminogen Activator Receptor (CD87) Is a Ligand for Integrins and Mediates Cell-Cell InteractionJournal of Biological Chemistry, 2001
- Regulation of Integrin Function by the Urokinase ReceptorScience, 1996
- Plasminogen activator inhibitor (PAI‐1) in plasma and plateletsBritish Journal of Haematology, 1988
- Fibrinolytic Pathways and the EndotheliumSeminars in Thrombosis and Hemostasis, 1987